2013至2018年英格兰大肠埃希菌菌血症耐药时间趋势与危险因素:一项生态学研究
该回顾性观察研究链接英国卫生安全局与BSAC耐药监测规划数据,分析2013年1月1日至2018年12月31日英格兰大肠埃希菌菌血症药敏记录,用迭代序贯回归估计耐药与多重耐药趋势,用逻辑回归分析危险因素。结果显示社区和医院起病菌血症对第三代头孢菌素、阿莫西林/克拉维酸、庆大霉素和环丙沙星的耐药率上升;社区获得性病例中>65岁患者感染对11种抗生素中至少一种耐药菌株的风险高于18-64岁者(OR 1.21,95%CI 1.18-1.25,P<0.05),医院起病病例中1-17岁者耐药风险高于18-64岁者(OR 1.33,95%CI 1.02-1.73,P<0.05)。
要点
- 2013至2018年英格兰大肠埃希菌菌血症对第三代头孢菌素、阿莫西林/克拉维酸、庆大霉素和环丙沙星耐药率上升。
- 社区获得性病例中>65岁患者对至少一种抗生素耐药的风险高于18-64岁者(OR 1.21,95%CI 1.18-1.25)。
- 医院起病病例中1-17岁患者耐药风险高于18-64岁者(OR 1.33,95%CI 1.02-1.73)。
核心结论
- 2013至2018年英格兰大肠埃希菌菌血症对关键抗菌药物的耐药率上升,研究结果对指导特定患者人群的抗菌药物处方政策有意义。
研究设计与样本
- 回顾性观察研究,纳入2013年1月1日至2018年12月31日英格兰所有大肠埃希菌菌血症药敏试验国家记录,数据来自英国卫生安全局和BSAC耐药监测规划。
主要发现
- 社区起病和医院起病菌血症对第三代头孢菌素、阿莫西林/克拉维酸、庆大霉素和环丙沙星的耐药率均上升。
- 社区获得性病例中,调整其他因素后,>65岁患者感染对11种抗生素中至少一种耐药的大肠埃希菌分离株的可能性高于18-64岁患者(OR 1.21,95%CI 1.18-1.25,P<0.05)。
- 医院起病病例中,1-17岁患者的大肠埃希菌分离株耐药可能性高于18-64岁患者(OR 1.33,95%CI 1.02-1.73,P<0.05)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Escherichia coli are Gram-negative bacteria associated with an increasing burden of antimicrobial resistance (AMR) in England. OBJECTIVES: To create a comprehensive epidemiological picture of E. coli bacteraemia resistance trends and risk factors in England by linking national microbiology data sources and performing a longitudinal analysis of rates. METHODS: A retrospective observational study was conducted on all national records for antimicrobial susceptibility testing on E. coli bacteraemia in England from 1 January 2013 to 31 December 2018 from the UK Health Security Agency (UKHSA) and the BSAC Resistance Surveillance Programme (BSAC-RSP). Trends in AMR and MDR were estimated using iterative sequential regression. Logistic regression analyses were performed on UKHSA data to estimate the relationship between risk factors and AMR or MDR in E. coli bacteraemia isolates. RESULTS: An increase in resistance rates was observed in community- and hospital-onset bacteraemia for third-generation cephalosporins, co-amoxiclav, gentamicin and ciprofloxacin. Among community-acquired cases, and after adjustment for other factors, patients aged >65 years were more likely to be infected by E. coli isolates resistant to at least one of 11 antibiotics than those aged 18-64 years (OR: 1.21, 95% CI: 1.18-1.25; P < 0.05). In hospital-onset cases, E. coli isolates from those aged 1-17 years were more likely to be resistant than those aged 18-64 years (OR: 1.33, 95% CI: 1.02-1.73; P < 0.05). CONCLUSIONS: Antibiotic resistance rates in E. coli-causing bacteraemia increased between 2013 and 2018 in England for key antimicrobial agents. Findings of this study have implications for guiding future policies on a prescribing of antimicrobial agents, for specific patient populations in particular.
引用
- Aliabadi S, Jauneikaite E, Müller-Pebody B, et al. Exploring temporal trends and risk factors for resistance in Escherichia coli-causing bacteraemia in England between 2013 and 2018: an ecological study. J Antimicrob Chemother. 2022. PMID: 34921311. doi:10.1093/jac/dkab440
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。